Aimed Bio Inc. (KOSDAQ:0009K0)
South Korea
· Delayed Price · Currency is KRW
62,700
-2,600 (-3.98%)
At close: Mar 9, 2026
Aimed Bio Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.05 | 0.11 |
| Debt / EBITDA Ratio | 0.12 | 0.40 | - | - |
| Net Debt / Equity Ratio | -0.94 | -0.78 | -0.98 | -0.53 |
| Net Debt / EBITDA Ratio | -18.12 | -33.23 | 3.21 | 1.04 |
| Net Debt / FCF Ratio | -6.28 | 6.88 | 4.99 | 1.15 |
| Asset Turnover | - | 0.34 | 0.01 | - |
| Quick Ratio | 24.47 | 16.91 | 4.24 | 6.99 |
| Current Ratio | 24.62 | 17.02 | 4.25 | 7.13 |
| Return on Equity (ROE) | - | -10.62% | -66.75% | - |
| Return on Assets (ROA) | - | -0.73% | -24.04% | - |
| Return on Capital Employed (ROCE) | 4.30% | -0.90% | -35.60% | -55.90% |
| Buyback Yield / Dilution | -18.19% | -3.86% | -2.16% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.